Clinical Trials in New York

Showing 3181-3200 of 13,173 trials

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

NCT05432193

This Phase 1 study will evaluate the safety and tolerability of \[Ga-68\]-PNT6555 and \[Lu-177\]-PNT6555 in subjects with select solid tumors that have FAP over-expression, in order to determine a recommended Phase 2 dose.

Pancreatic Ductal AdenocarcinomaColorectal CancerEsophageal Cancer+4 more

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company20 participantsStarted Jul 2022

New York, New York, United States • Toronto, Ontario, Canada • Montreal, Quebec, Canada +1 more locations

Active Not RecruitingPhase 3< 1 mile

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

NCT05037123

The study utilizes a 3-arm placebo-controlled RCT to study the effectiveness of ketamine in reducing chronic post-mastectomy pain. Participants randomized to the first arm will receive a 0.35 mg/kg dose after induction, followed by a 0.25 mg/kg/hr infusion during surgery (up to a maximum of 6 hours) and continued for 2 hours postoperatively. Participants in the second arm will receive a single dose of 0.6 mg/kg of ketamine in the post-anesthesia care unit, and the final group will serve as the control group and receive saline (no ketamine).

Chronic Postsurgical Pain

NYU Langone Health765 participantsStarted Jan 2022

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Chicago, Illinois, United States +11 more locations

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

Find Trials by Condition in New York

Pembrolizumab for Advanced NSCLC and PS 2-3

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

Effect of Novel High Dissolving Transitional Foods

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide

Telehealth Group Counseling and Preventive Care for Women

Mobile CBT for Middle Aged and Older Adults

Cannabidiol in Sickle Cell Disease

Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events

ExaStim Upper Limb Home Use Clinical Validation Study

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer